Latest News

Super PAC spends millions to support Menendez's re-election effort

An independent national patient organization has spent more than $3 million on behalf of Sen. Bob Menendez (D-New Jersey) in his campaign for re-election.

State institution: These 4-year U.S. schools attract the most in-state students

Chamberlain University-New Jersey and University of Phoenix-New Jersey enrolled the most in-state students of all four-year schools in the U.S., according to a Higher Education Tribune analysis of fall 2017 data.

CELGENE CORPORATION: Celgene Named Among World’s Best Employers 2018

Celgene has long maintained a dual focus on not only the patients that its therapies treat but the employees at Celgene that work to develop those therapies and get them to market.

CELGENE CORPORATION: New Survey Reveals Myelodysplastic Syndromes Leave Patients Feeling Fatigued

While understanding the impact of myelodysplastic syndromes (MDS) on the lives of people diagnosed with these blood cancers can help inform their care, assessments of quality of life in MDS have been, for the most part, lacking.

CORPORATE ESSENTIALS: Introducing November’s James Beard Award Nominated Chef: Bonnie Morales

Autumn calls for cuisine rich in flavors and seasonings, providing a feeling of comfort on a chilly day.

KONICA MINOLTA BUSINESS SOLUTIONS U.S.A, INC: Konica Minolta Supports the National Kidney Foundation in the Fight Against Kidney Disease

This Sunday, Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) will continue their support of the National Kidney Foundation and the fight against kidney disease by walking in the 2018 New York City Kidney Walk.

MERCK: FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.

State institution: These 4-year New Jersey schools attract the fewest in-state students

Yeshiva Gedolah Shaarei Shmuel, Rabbinical College of America and Bais Medrash Toras Chesed enrolled the fewest in-state students of all four-year New Jersey schools, according to a Higher Education Tribune analysis of fall 2017 data.

KONICA MINOLTA BUSINESS SOLUTIONS U.S.A, INC: Konica Minolta’s AccurioJet KM-1 UV Inkjet Press Offers New Opportunities to Expand Small Business Client Base

Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) is pleased to announce that our Accuriojet KM-1 UV Inkjet press continues to transform small and medium-sized businesses (SMBs) by expanding their opportunities to break into new markets, offer new products, and increase profits.

MERCK: FDA Accepts Regulatory Submission for LYNPARZA® (olaparib) Maintenance Therapy in Newly-Diagnosed, BRCA-Mutated Advanced Ovarian Cancer and Grants Priority Review

AstraZeneca and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for priority review for the approval of LYNPARZA tablets as a maintenance treatment in patients with newly-diagnosed, BRCA-mutated (BRCAm) advanced ovarian cancer who were in complete or partial response following first-line standard platinum-based chemotherapy.

NEW JERSEY CHAMBER OF COMMERCE: Statement from N.J. Chamber of Commerce President Tom Bracken on the Amazon Headquarters Decision

We wish Amazon success with its new headquarters in Crystal City, Virginia, and Long Island City in Queens, New York.

MERCK: Merck Begins Rolling Submission of Licensure Application for V920 (rVSV∆G-ZEBOV-GP) to U.S. Food and Drug Administration

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that it has started the submission of a rolling Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for V920 (rVSV∆G-ZEBOV-GP, live attenuated), the company’s investigational vaccine for Ebola Zaire disease.

BASF CORPORATION: Making a lab that fits in your pocket

In its latest example of innovation performance, BASF has developed HertzstückTM, a groundbreaking infrared detector that may soon transform smartphones into pocket-sized portable laboratories.

These 4-year schools have the top 'on time' graduation rates in New Jersey

Princeton University, The College of New Jersey and Stevens Institute of Technology have the best 'on time' graduation rates among four-year schools in New Jersey, according to a Higher Education Tribune analysis of federal data.

These 4-year schools have the worst 'on time' graduation rates in New Jersey

Rabbinical College of America, Rabbi Jacob Joseph School and Yeshiva Toras Chaim have the lowest 'on time' graduation rates among four-year schools in New Jersey, according to a Higher Education Tribune analysis of federal data.

NEW JERSEY CHAMBER OF COMMERCE: Chamber CEO Bracken recognized for work on TTF legislation

The New Jersey League of Municipalities on Thursday awarded Tom Bracken, president and CEO of the New Jersey Chamber of Commerce, its Distinguished Public Service Award.

NEW JERSEY CHAMBER OF COMMERCE: How Chit Chat Diner saved the day (and night) for West Orange school kids caught on buses in storm

As he and his staff looked out the windows of the newly renovated and recently opened Chit Chat Diner in West Orange early Thursday afternoon, shift manager Leo Novakidis couldn’t help but notice a few school buses that were stuck in traffic along with just about everyone else in North Jersey.

GREATER ELIZABETH CHAMBER OF COMMERCE: December 4, 2018 | Hilton Newark Airport – Annual Holiday Social

On Tuesday, December 4, mix and mingle with fellow chamber members and explore what the GECC has to offer!

CELGENE CORPORATION: Helping Veterans with Lung Cancer

Lung cancer remains the leading cause of cancer-related death in both men and women in the United States.

KONICA MINOLTA BUSINESS SOLUTIONS U.S.A., INC: Konica Minolta To Exhibit At Print 19 Expo

Konica Minolta Business SolutionsU.S.A., Inc. (Konica Minolta) is pleased to announce it will again be showcasing its award-wining digital print technologies at Print 19 in Chicago, October 3-5, 2019.

Metro Business Network